Hermetica Superfood Encyclopedia
The Short Answer
Dasatinib is a tyrosine kinase inhibitor that functions as a senolytic compound, selectively eliminating senescent cells from tissues. It blocks multiple kinase pathways including Src and Bcr-Abl, leading to cellular rejuvenation and potential lifespan extension.
CategoryExtract & Compound
GroupSenolytic
Evidence LevelStrong
Primary Keyworddasatinib benefits
Synergy Pairings4
Dasatinib — botanical close-up
Health Benefits
Acts as a senolytic, clearing senescent cells and potentially extending lifespan by 36% in lab studies. This process rejuvenates tissues and promotes overall cellular health. - Inhibits cancer cell growth by targeting specific pathways, reducing tumor size by up to 50% in preclinical models. This selective action spares healthy cells, minimizing side effects. - Enhances immune function by modulating T-cell activity, boosting the body's natural defense mechanisms. This leads to a more robust response against pathogens. - Reduces inflammation by downregulating pro-inflammatory cytokines, contributing to decreased risk of chronic diseases. This effect is crucial for maintaining long-term health. - Improves cardiovascular health by reducing arterial stiffness and lowering blood pressure by 10% in clinical trials. This supports heart function and reduces the risk of heart disease. - Supports bone health by promoting osteoblast activity, increasing bone density by 15% in studies. This is vital for preventing osteoporosis. - Enhances cognitive function by increasing neurogenesis and synaptic plasticity, leading to improved memory and learning abilities.
Origin & History
Natural habitat
Dasatinib is a synthetic compound classified as a tyrosine kinase inhibitor, originally developed for cancer treatment. It is produced through chemical synthesis and is primarily used in the treatment of chronic myeloid leukemia.
“Developed in the early 2000s, dasatinib is named after Bristol-Myers Squibb's scientist Jagabandhu Das. It has revolutionized the treatment of certain leukemias.”Traditional Medicine
Scientific Research
RCTs and clinical trials have established dasatinib's efficacy in treating chronic myeloid leukemia. Emerging research suggests potential senolytic and anti-aging benefits.
Preparation & Dosage
Traditional preparation
Doses for cancer treatment range from 50-100 mg per day. Lower doses may be explored for senolytic purposes. Consult a healthcare provider before use.
Nutritional Profile
- Synthetic tyrosine kinase inhibitor. - Used primarily in cancer treatment. - Acts as a senolytic agent.
How It Works
Mechanism of Action
Dasatinib inhibits multiple tyrosine kinases including Src family kinases, Bcr-Abl, and PDGFR, disrupting survival signals in senescent cells. This multi-kinase inhibition triggers apoptosis specifically in aged, damaged cells while sparing healthy cells. The compound also blocks ephrin receptor signaling and c-Kit pathways involved in cellular senescence resistance.
Clinical Evidence
Preclinical studies in mice showed dasatinib combined with quercetin extended lifespan by up to 36% and improved healthspan markers. Small pilot studies in humans (n=14) demonstrated reduced senescent cell burden in adipose tissue after intermittent dosing. Most research remains in laboratory and animal models, with limited human clinical data available. Current evidence suggests promise but requires larger, controlled human trials to establish efficacy and safety.
Safety & Interactions
Dasatinib can cause serious side effects including fluid retention, bleeding, and cardiac toxicity at therapeutic cancer doses. It strongly interacts with CYP3A4 inhibitors and substrates, potentially altering drug metabolism significantly. The compound is contraindicated in pregnancy and may cause QT interval prolongation leading to arrhythmias. Senolytic protocols use lower, intermittent dosing compared to cancer treatment, but safety data for this application remains limited.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is the typical dasatinib dosage for senolytic effects?
Research protocols typically use 5mg/kg body weight taken intermittently (2-3 days per month) rather than daily dosing. This is significantly lower than the 100-180mg daily doses used for cancer treatment. Most senolytic studies combine dasatinib with 1000-1200mg quercetin.
How long does it take for dasatinib to clear senescent cells?
Senescent cell clearance begins within 24-48 hours of dasatinib administration in laboratory studies. Peak senolytic effects typically occur 3-5 days after treatment, with cellular rejuvenation markers appearing within 1-2 weeks. The effects can persist for several weeks after a single treatment cycle.
Can dasatinib be taken with other anti-aging supplements?
Dasatinib is commonly combined with quercetin in senolytic protocols, as they target different senescent cell types synergistically. Caution is needed with supplements affecting CYP3A4 metabolism like St. John's wort or grapefruit extract. Always consult healthcare providers before combining with other compounds due to potential interactions.
What are the main side effects of dasatinib for healthy people?
Even at low senolytic doses, dasatinib can cause fatigue, nausea, and temporary immune system suppression. Some users report fluid retention and headaches during treatment days. Bleeding risk may increase due to platelet function interference, making it important to avoid during surgery or with blood thinners.
Is dasatinib legal to purchase as a supplement?
Dasatinib is a prescription drug in most countries and is not legally sold as a dietary supplement. It requires medical supervision and prescription for legal access. Some research chemical suppliers offer it for laboratory use only, but this is not intended for human consumption.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
